Oscar Health, Inc. (OSCR) Stock Price & Analysis
Oscar Health, Inc. (OSCR) fell 0.62% to USD 27.22 as of June 10, 2026 at 00:27 UTC, according to Nexqual real-time market data.
OSCR last closed at USD 27.39; the session ranged USD 26.08–28.16 on volume of 8,049,331 shares. Market capitalization is $8.21B, with a 52-week range of USD 10.69–28.16 (NYQ). Source: Nexqual, June 10, 2026 at 00:27 UTC.
Key Statistics (as of June 10, 2026 at 00:27 UTC)
| Price | USD 27.22 |
|---|---|
| Change | ▼ 0.62% (down) |
| Previous Close | USD 27.39 |
| Open | USD 27.4 |
| Day Range | USD 26.08 – 28.16 |
| 52-Week Range | USD 10.69 – 28.16 |
| Volume | 8,049,331 shares |
| Market Cap | $8.21B |
| Exchange | NYQ |
Technical Analysis (OSCR)
Nexqual's technical model rates OSCR "BUY" based on 5 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 00:27 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 71.03 (overbought) |
| vs SMA50 | Above (USD 19.07) |
| MACD | 1.62 (positive) |
Analyst Ratings (OSCR)
Wall Street analysts rate OSCR "Hold" based on 10 analysts, with a mean price target of USD 22.1 (range USD 13–30), per Nexqual as of June 10, 2026 at 00:27 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 10 |
| Mean Target | USD 22.1 |
| High Target | USD 30 |
| Low Target | USD 13 |
| Buy / Hold / Sell | 2 / 8 / 1 |
Earnings (OSCR)
| Next Earnings Date | 2026-05-06 |
|---|---|
| EPS Estimate | USD 0.33 |
| Revenue Estimate | $4.74B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 2.07 vs est 1.1 ▲ beat |
| 2025-12-31 | USD -1.24 vs est -0.92 ▼ miss |
| 2025-09-30 | USD -0.53 vs est -0.58 ▲ beat |
| 2025-06-30 | USD -0.89 vs est -0.84 ▼ miss |
Source: Nexqual, June 10, 2026 at 00:27 UTC.
Financials & Fundamentals (OSCR)
| Total Revenue | $13.30B |
|---|---|
| Revenue Growth (YoY) | +52.60% |
| Gross Margin | +17.39% |
| Operating Margin | +15.15% |
| Profit Margin | -0.30% |
| ROE | -2.62% |
| Debt / Equity | 28.93 |
| Current Ratio | 1.09 |
| Total Cash | $6.80B |
| Total Debt | $482.24M |
| Free Cash Flow | $1.63B |
Source: Nexqual, June 10, 2026 at 00:27 UTC.
Financial Health Score (OSCR)
Nexqual rates Oscar Health, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:27 UTC.
| Growth | Strong — Revenue +28% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 17%, operating 15% |
| Balance Sheet | Strong — $6.80B cash vs $482M debt, net cash position |
| Cash Flow | Solid — FCF $1.63B, 14% margin |
| Efficiency | Critical — ROE -3%, ROA 0.1% |
Ownership (OSCR)
| Insider Ownership | +5.36% |
|---|---|
| Institutional Ownership | +67.50% |
| Shares Outstanding | 265.90M |
| Float | 246.83M |
| Short % of Float | +7.34% |
Source: Nexqual, June 10, 2026 at 00:27 UTC.
Leadership (OSCR)
Oscar Health, Inc. is led by Mark Thomas Bertolini (age 68), CEO & Director, per Nexqual as of June 10, 2026 at 00:27 UTC.
| CEO & Director | Mark Thomas Bertolini (age 68) |
|---|---|
| Co-Founder & Vice Chairman | Joshua Kushner (age 40) |
| Co-Founder, Advisor to the CEO & Director | Mario Tobias Schlosser (age 46) |
| Chief Financial Officer | Richard Scott Blackley (age 57) |
| EVP & President of Oscar Insurance | Janet Ann Liang (age 57) |
Major Backers & Investors (OSCR)
Notable institutional backers of Oscar Health, Inc. include T. Rowe Price, American Century Companies Inc, Thrive Capital Management, LLC, according to Nexqual as of June 10, 2026 at 00:27 UTC.
Active Investors
| Investor | Stake |
|---|---|
| T. Rowe Price | 6.13% |
| American Century Companies Inc | 5.01% |
| Thrive Capital Management, LLC | 2.39% |
| BIT Capital GmbH | 2.38% |
| Shaw D.E. & Co., Inc. | 2.06% |
| Fidelity | 0.73% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 15.28% |
| BlackRock | 8.93% |
| State Street | 1.98% |
| Geode Capital | 1.89% |
Source: Nexqual, June 10, 2026 at 00:27 UTC.
From Oscar Health, Inc.'s Latest SEC 10-K Filing (filed 2026-02-13)
Key Strengths & Strategy (as disclosed to the SEC)
- As of December 31, 2025, we owned no issued patents or pending patent applications anywhere in the world, and therefore, we do not have patent protection for any of our proprietary technology, which includes our full stack technology platform, proprietary software, mobile application ("app"), or web portal.
- OUR BUSINESS Oscar is a leading healthcare technology company built around a full stack technology platform and a relentless focus on member experience.
- We partner with third parties, including Amazon and Google, to support our information technology systems.
- As an example, we distribute our Amazon Web Services ("AWS") hosted platform across multiple availability zones in an effort to reduce the likelihood of infrastructure failure.
Partnerships
- For the year ended December 31, 2025, 93% of premiums were earned directly from CMS and 7% were from our members. 6 Table of Contents Disaggregated membership information as of December 31, 2025 and 2024 is presented in the tables below: (1) Represents total membership for our co-branded partnership with Cigna.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HIMS | Hims & Hers Health, Inc. | USD 28.98 | ▲ 10.65% |
| ZETA | Zeta Global Holdings Corp. | USD 21.08 | ▼ 4.27% |
| GRAB | Grab Holdings Limited | USD 3.3 | ▼ 1.2% |
| TEM | Tempus AI, Inc. | USD 48.82 | ▲ 5.15% |
| IREN | IREN LIMITED | USD 54.02 | ▼ 0.61% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:27 UTC. This page is informational and not investment advice.